Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

LY 288513

Known as: LY288513 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague–Dawley rats using elevated plus-maze test apparatus
1998
1998
Cholecystokinin B receptors in the periaqueductal gray potentiate defensive rage behavior elicited from the medial hypothalamus of the cat
Highly Cited
1997
Highly Cited
1997
Cholecystokinin and Psychiatric Disorders
SummaryCholecystokinin (CCK) is one of the most abundant neuropeptides in the brain. It is found in the highest levels in… 
  • table I
  • table II
1997
1997
The novel atypical antipsychotic olanzapine, but not the CCK-B antagonist LY288513, blocks apomorphine-induced disruption of pre-pulse inhibition
1996
1996
Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo.
The potency and specificity of five proposed cholecystokinin-B receptor antagonists, YM022, RP73870, L-740,093, L-365,260 and… 
1996
1996
Central nervous system characterization of the new cholecystokininB antagonist LY288513
1996
1996
The CCK‐B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle
IN order to explore the potential clinical utility of CCK-B antagonists for the treatment of nicotine withdrawal symptoms, the… 
1994
1994
The CCK‐B Antagonist LY288513 Blocks Diazepam‐Withdrawal‐Induced Increases in Auditory Startle Response
In humans, withdrawal from the chronic use of benzodiazepines can result in a variety of undesirable side effects, including… 
Highly Cited
1993
Highly Cited
1993
Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.
The diphenylpyrazolidinone cholecystokinin (CCK)-B antagonist LY262691 has recently been demonstrated to decrease the number of… 
1993
1993
The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle.
In order to explore the potential clinical utility of CCK-B antagonists for the treatment of benzodiazepine withdrawal symptoms… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE